Counselors in Sapulpa, OK Accepting Medicare
144 Counselors found. Showing 61 - 80
 Christy Anderson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 |
Mrs. Stacy D Sexton Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 Fax: 918-227-1125 |
Audria Bobbitt Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 |
April Heather Reeder, M.A. AND M.DIV Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 |
Emily Storz Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 Fax: 918-216-4998 |
Sarah Taylor Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 Fax: 918-216-4998 |
Mrs. Alexandria Paige Burns, LPC-CANDIDATE Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 |
Mrs. Lula Diann Smith Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 Fax: 918-227-1125 |
Misty Murray Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 Fax: 918-216-4998 |
Mrs. Anna Mae Hitsman Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6531 S. 126th West Ave, Sapulpa, OK 74066 Phone: 918-224-3989 |
Caitlen Denise Berryhill Counselor Medicare: Not Enrolled in Medicare Practice Location: 1304 E Lincoln Ave, Sapulpa, OK 74066 Phone: 918-951-5771 |
Robin Lynn Spears, LPC, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2 N Water St, Sapulpa, OK 74066 Phone: 918-224-0225 |
Mary Temple Hull Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 |
Ms. Laura L. Savage, M.S., LPC, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 32 N Water St, Sapulpa, OK 74066 Phone: 918-224-9185 Fax: 918-224-9211 |
 Jeremy Miller Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 Fax: 918-216-4998 |
Ms. Gaye Lajean Wheeler, BA, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2 N Water St, Sapulpa, OK 74066 Phone: 918-224-0225 |
Emma Howard Counselor Medicare: Not Enrolled in Medicare Practice Location: 2 N Water St, Sapulpa, OK 74066 Phone: 918-224-0225 |
Suzanne Stocker Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 Fax: 918-227-1125 |
Mr. Kenneth D. Price, STUDENT INTERN Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 Fax: 918-227-1125 |
Mrs. Mindy Marie Littlefield Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-227-2016 Fax: 918-227-2023 |
News Archive
Clinical study shows sitagliptin drug not effective in treating NAFLD
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
New findings from a safety and feasibility clinical trial on removal of senescent cells
Mayo Clinic researchers, along with collaborators from Wake Forest School of Medicine and the The University of Texas Health Sciences Center at San Antonio, have published findings from a safety and feasibility clinical trial on the removal of senescent cells from a small group of patients with pulmonary fibrosis
Doris Duke Innovations award for sickle cell disease research
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
An economic side effect of cancer treatment
Many cancer survivors with high medical copayments experience financial toxicity, an economic side effect of cancer treatment.
XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.
› Verified 2 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Marriage Counselors
Psychologists
Occupational Therapists